» Articles » PMID: 24528214

Associations of Genetic Variants In/near Body Mass Index-associated Genes with Type 2 Diabetes: a Systematic Meta-analysis

Abstract

Objective: Genome-wide association studies have identified many obesity/body mass index (BMI)-associated loci in Europeans and East Asians. Since then, a large number of studies have investigated the role of BMI-associated loci in the development of type 2 diabetes (T2D). However, the results have been inconsistent. The objective of this study was to investigate the associations of eleven obesity/BMI loci with T2D risk and explore how BMI influences this risk.

Methods: We retrieved published literature from PubMed and Embase. The pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using fixed- or random-effect models.

Results: In the meta-analysis of 42 studies for 11 obesity/BMI-associated loci, we observed a statistically significant association of the FTO rs9939609 polymorphism (66 425 T2D cases/239 689 normoglycaemic subjects; P = 1·00 × 10(-41) ) and six other variants with T2D risk (17 915 T2D cases/27 531 normoglycaemic individuals: n = 40 629-130 001; all P < 0·001 for SH2B1 rs7498665, FAIM2 rs7138803, TMEM18 rs7561317, GNPDA2 rs10938397, BDNF rs925946 and NEGR1 rs2568958). After adjustment for BMI, the association remained statistically significant for four of the seven variants (all P < 0·05 for FTO rs9939609, SH2B1 rs7498665, FAIM2 rs7138803, GNPDA2 rs10938397). Subgroup analysis by ethnicity demonstrated similar results.

Conclusions: This meta-analysis indicates that several BMI-associated variants are significantly associated with T2D risk. Some variants increase the T2D risk independent of obesity, while others mediate this risk through obesity.

Citing Articles

Association of fat mass and obesity-associated () gene polymorphisms with non-communicable diseases (NCDs) in the Iranian population: A systematic review of observational studies.

Hoseini Tavassol Z, Mousavi S, Molaei B, Bandarian F, Ejtahed H, Khalagi K J Diabetes Metab Disord. 2022; 21(2):1975-1989.

PMID: 36404828 PMC: 9672241. DOI: 10.1007/s40200-022-01139-4.


"GENYAL" Study to Childhood Obesity Prevention: Methodology and Preliminary Results.

Marcos-Pasero H, Aguilar-Aguilar E, de la Iglesia R, Espinosa-Salinas I, Molina S, Colmenarejo G Front Nutr. 2022; 9:777384.

PMID: 35350411 PMC: 8957940. DOI: 10.3389/fnut.2022.777384.


CNS GNPDA2 Does Not Control Appetite, but Regulates Glucose Homeostasis.

Gutierrez-Aguilar R, Grayson B, Kim D, Yalamanchili S, Calcagno M, Woods S Front Nutr. 2021; 8:787470.

PMID: 34912841 PMC: 8666973. DOI: 10.3389/fnut.2021.787470.


Effects of epigallocatechin gallate on total antioxidant capacity, biomarkers of systemic low-grade inflammation and metabolic risk factors in patients with type 2 diabetes mellitus: the role of -rs9939609 polymorphism.

Hosseini S, Alipour M, Zakerkish M, Cheraghian B, Ghandil P Arch Med Sci. 2021; 17(6):1722-1729.

PMID: 34900054 PMC: 8641491. DOI: 10.5114/aoms.2020.95903.


Analysis of Polymorphisms rs7093069-IL-2RA, rs7138803-FAIM2, and rs1748033-PADI4 in the Group of Adolescents With Autoimmune Thyroid Diseases.

Sawicka B, Borysewicz-Sanczyk H, Wawrusiewicz-Kurylonek N, Aversa T, Corica D, Goscik J Front Endocrinol (Lausanne). 2020; 11:544658.

PMID: 33193078 PMC: 7645032. DOI: 10.3389/fendo.2020.544658.


References
1.
Song Y, You N, Hsu Y, Howard B, Langer R, Manson J . FTO polymorphisms are associated with obesity but not diabetes risk in postmenopausal women. Obesity (Silver Spring). 2008; 16(11):2472-80. PMC: 2732012. DOI: 10.1038/oby.2008.408. View

2.
Scott L, Mohlke K, Bonnycastle L, Willer C, Li Y, Duren W . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316(5829):1341-5. PMC: 3214617. DOI: 10.1126/science.1142382. View

3.
Wen J, Ronn T, Olsson A, Yang Z, Lu B, Du Y . Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One. 2010; 5(2):e9153. PMC: 2818850. DOI: 10.1371/journal.pone.0009153. View

4.
Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T . Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008; 359(21):2220-32. DOI: 10.1056/NEJMoa0801869. View

5.
Bravard A, Lefai E, Meugnier E, Pesenti S, Disse E, Vouillarmet J . FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Diabetes. 2010; 60(1):258-68. PMC: 3012179. DOI: 10.2337/db10-0281. View